1. Home
  2. ADXN vs UGRO Comparison

ADXN vs UGRO Comparison

Compare ADXN & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$6.12

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$19.05

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADXN
UGRO
Founded
2002
2014
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
13.2M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
ADXN
UGRO
Price
$6.12
$19.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
10.9M
Earning Date
04-24-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
$86.57
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$0.11
52 Week High
$12.05
$39.68

Technical Indicators

Market Signals
Indicator
ADXN
UGRO
Relative Strength Index (RSI) 41.16 61.54
Support Level $5.57 $0.71
Resistance Level $8.60 $39.68
Average True Range (ATR) 0.52 7.35
MACD 0.00 0.61
Stochastic Oscillator 33.62 45.64

Price Performance

Historical Comparison
ADXN
UGRO

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: